GlassScriptPhysician profile
Joseph Martin Ehrhard
NPI 1306836911
$13,742.45
in general payments reported to CMS, 2019-2025
11 companies · $11K in 2025
The $11K reported for 2025 was more than what 99% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,797 · 2022: $18.87 · 2023: $327 · 2024: $224 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,225 · Travel and Lodging: $1,592 · Food and Beverage: $973 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,224.74 |
| Travel and Lodging | $1,591.63 |
| Food and Beverage | $972.79 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $8,287.20 | 2024-2025 | Stratafix, Orthovisc, Monovisc |
| Ethicon US, LLC | $2,997.51 | 2025 | |
| Arthrex, INC. | $1,412.00 | 2021 | |
| Legacy Ortho LLC | $385.41 | 2021 | |
| Bioventus LLC | $154.44 | 2023-2024 | Durolane, Durolane |
| Depuy Synthes Sales INC. | $139.93 | 2025 | Orthovisc, Monovisc |
| Abbott Laboratories | $130.08 | 2025 | Proclaim |
| Astellas Pharma US INC | $125.00 | 2023 | Cresemba |
| Si-Bone, INC. | $71.37 | 2023 | |
| Curonix LLC | $20.64 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Endo Pharmaceuticals INC. | $18.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ehrhard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.